Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adalimumab for Osteoarthritis of the Knee (OKINADA)
NCT02471118Phase 2Completed
- Sponsor
- CARE Arthritis
- Start
- Mar 2015
- Primary completion
- Mar 2021
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in osteoarthritis (OA) comparing Adalimumab with Placebo (2 arms). Primary endpoint: Osteoarthritis Research Society International/Outcome Measures in Rheumatology Clinical trials Response at 16 weeks. Started Mar 2015; status: completed.
02
Drugs
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT02471118.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02471118.